Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge

The results come amid investor anxiety over the thousands of lawsuits claiming that J&J’s talc-based baby powder and other products caused cancer.The results come amid investor anxiety over the thousands of lawsuits claiming that J&J’s talc-based baby powder and other products caused cancer. 

​ 

Leave a Reply

Your email address will not be published. Required fields are marked *

Search this website